Trial intelligence / Profile preview

Lorazepam for perioperative anxiety in elective hernia surgery

IRCT20260226068959N2Phase 3Completed

Sponsor
North Khorasan University of Medical Sciences
Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in anxiety disorder comparing Lorazepam with Placebo (2 arms). Primary endpoints: Anxiety score, Pain score and 1 more. Started Apr 2026; status: completed.

02

Drugs

lorazepam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on IRCT20260226068959N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260226068959N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call